7461-3 Navigating Medication for Addiction Treatment (MAT) and Embracing Harm Reduction in Substance Use Disorder-Recording

Video Transcription

Video Summary

The video transcript is about a session on medication for addiction treatment and harm reduction strategies led by Chelsea Kimura and Stephanie. They discussed the importance of acknowledging substance use disorder as a chronic disease requiring long-term management and the role of medications like buprenorphine and methadone in restoring dopamine levels to reduce cravings. Harm reduction strategies were highlighted as a public health approach to minimize negative consequences associated with substance use, aimed at supporting individuals where they are at in their journey. The session emphasized the need for compassionate and non-coercive support, involving community engagement and peer-led services. The goal is to empower individuals in making positive changes and enhancing safety. The presentation concluded with a discussion on why treatment for substance use disorder should be treated like a chronic disease and encouraged participants to consider the importance of medication for addiction treatment in supporting long-term recovery.

Keywords

medication

addiction treatment

harm reduction

substance use disorder

buprenorphine

methadone

chronic disease